Robert B. Bhisitkul, MD, PhD

Dr. Bhisitkul, Professor of Ophthalmology, Alex Irvine MD Endowed Chair at the University of California San Francisco School of Medicine, has over 20 years of experience as a retina surgeon and clinician scientist. Dr. Bhisitkul graduated from Stanford University then combined medical school at Stanford with his PhD in Neurosciences at Yale University, followed by residency and fellowship training at Harvard Medical School/Massachusetts Eye and Ear Infirmary. His translational research interest is in pre-clinical development of novel technologies for ophthalmic diseases, and he is co-founder of Oculinea Therapeutics. In clinical research, he is an investigator in major clinical trials of novel ophthalmic therapeutics, as well as studies of long-term outcomes of drug treatments for chronic eye disease. He is Director for the UCSF Retina Fellowship program. He is an Associate Examiner for the American Board of Ophthalmology, a recipient of the American Academy of Ophthalmology Achievement Award, and has served as an editorial board member of American Journal of Ophthalmology Case Reports and as associate editor of the British Journal of Ophthalmology. He acts as consultant and medical advisor for ophthalmologic pharmaceutical companies in designing early-stage trials and conducting clinical development of new ocular therapies.